 |
| "It is going to alright, baby. Mommy blew the whistle on all of them, including Rick." |
FUN FACT! HYDROXYCHLOROQUINE IS A TEVA GENERIC
https://beverlytran.blogspot.com/search?q=TEVA
Rick was also involved in the Public Private Partnership of the Biomedical Advanced Research and Development Authority, where they like targeted populations.
That is Medicaid Fraud in Child Welfare.
According to Wikipedia, Rick has a history of using tiny humans inside their mommies' tummies as lab rats.
From 1998 to 2002, Bright worked at the Centers for Disease Control and Prevention in Atlanta, Georgia, in the Influenza Branch, Immunology and Viral Pathogenesis Section, where he studied Influenza A virus subtype H5N1.[8]From 2002 to 2003, Bright shifted to working at the pharmaceutical company, Altea Therapeutics (a subsidiary of Nitto Denko) in Atlanta, Georgia, where he was a senior research scientist in their Vaccine and Immunology Programs.[8][11]In 2003, Bright rejoined the CDC as an immunologist/virologist in their Disease Control and Prevention, Influenza Division, Strain Surveillance Branch in Atlanta, Georgia, where he worked on their influenza antiviral drug program and focused on avian influenza. He held that position until 2006.[8][12]From 2006 to 2008, Bright returned to working in the private sector of the biotechnology industry at Novavax in Maryland, where he was vice president of their global influenza programs as well as of their vaccine research and development. During this time, he participated in World Health Organization committees on vaccine development and pandemic preparedness.[8][11][13]In February 2008, Bright worked at the non-profit PATH on a Bill & Melinda Gates Foundation grant funded project as the director in vaccine manufacturing capacity building in Viet Nam. He was also the scientific director of the influenza vaccine project as well as the global vaccine development program, a position he held until October 2010.[8]In 2010, Bright joined the U.S. Department of Health and Human Services (HHS) governmental agency Biomedical Advanced Research and Development Authority (BARDA). He was the program lead of BARDA International Programs, then in June 2011 became acting chief of the influenza antiviral drug advanced development program, a position he held until December 2011. From June 2011 to December 2015, he was both deputy director and acting director of BARDA's Influenza and Emerging Diseases Division, eventually serving as director of the division from December 2014 to November 2016. From February 2016 to November 2016, he was an incident commander in the ASPR/BARDA Zika Response.[8][14]
Rick Bright will warn Congress of 'darkest winter in modern history' without ramped up coronavirus response
(CNN)Dr. Rick Bright, the ousted director of a key federal office charged with developing medical countermeasures, will testify before Congress on Thursday that the Trump administration was unprepared for the coronavirus pandemic and warn that the the US will face "unprecedented illness and fatalities" without additional preparations.
"Our window of opportunity is closing. If we fail to develop a national coordinated response, based in science, I fear the pandemic will get far worse and be prolonged, causing unprecedented illness and fatalities," Bright is expected to say Thursday, according to his prepared testimony obtained by CNN. "Without clear planning and implementation of the steps that I and other experts have outlined, 2020 will be darkest winter in modern history."
Bright is set to testify Thursday morning before the House Committee on Energy and Commerce's health subcommittee after he filed a whistleblower complaint last week alleging he was removed from his post in retaliation for opposing the broad use of a drug frequently touted by President Donald Trump as a coronavirus treatment.
Bright will reiterate that he believes he was removed from his post because he "resisted efforts to promote and enable broad access to an unproven drug, chloroquine, to the American people without transparent information on the potential health risks."
Bright is seeking to be reinstated to his position as the head of the Biomedical Advanced Research and Development Authority (BARDA) and the Office of Special Counsel, which is reviewing Bright's complaint, has determined there is reason to believe his removal was retaliatory and is recommending he be reinstated during its investigation, according to Bright's attorneys.
A Department of Health and Human Services spokesperson responded that it was "a personnel matter that is currently under review" but said it "strongly disagrees with the allegations and characterizations."
Expanding on his whistleblower complaint, Bright is expected to testify that he sought to warn his superiors about potential shortages of critical medical supplies earlier this year, but that his "urgency was dismissed" and that he "faced hostility and marginalization from HHS officials" after conveying his concerns about shortages to a senior White House official, Peter Navarro.
"As I reflect on the past few months of this outbreak, it is painfully clear that we were not as prepared as we should have been. We missed early warning signals and we forgot important pages from our pandemic playbook," Bright will testify, according to his written testimony.
In his written testimony, Bright also calls for several key steps to improve the federal government's response to the pandemic and head off a spike in cases in the fall, including increasing public education of preventative measures, ramping up production of essential medical supplies and developing a national testing strategy.
"The virus is out there, it's everywhere. We need to be able to find it, to isolate it and to stop it from infecting more people," Bright plans to say. "We need tests that are accurate, rapid, easy to use, low cost, and available to everyone who needs them."
He made his complaint public through Washington Post but failed to release the 33 attachments to the committee.
He did not follow the well established chain of command for filing a whistleblower action.
He sounds like he was coached by one of those absolutely brilliant "Legal Geniuses" (trademark pending).
I guess Rick was blinded by science when it comes to the rule of law in actions of false claims.
I would have fired him, too.
His complaint was pending and I see no certification of verification.
He made his complaint public through Washington Post but failed to release the 33 attachments to the committee.
He did not follow the well established chain of command for filing a whistleblower action.
He sounds like he was coached by one of those absolutely brilliant "Legal Geniuses" (trademark pending).
I guess Rick was blinded by science when it comes to the rule of law in actions of false claims.
I would have fired him, too.
His complaint was pending and I see no certification of verification.
READ: Rick Bright's full whistleblower complaint
Voting is beautiful, be beautiful ~ vote.©
